Skip to main content
BioMarin Pharmaceutical Inc. (LON:0HNC)
London flag London · Delayed Price · Currency is GBP · Price in USD
62.28
+1.59 (2.62%)
At close: Apr 23, 2025

BioMarin Pharmaceutical Revenue

In the year 2024, BioMarin Pharmaceutical had annual revenue of $2.85B USD with 17.97% growth. BioMarin Pharmaceutical had revenue of $747.31M in the quarter ending December 31, 2024, with 15.65% growth.

Revenue
$2.85B
Revenue Growth
+17.97%
P/S Ratio
3.92
Revenue / Employee
$938.79K
Employees
3,040
Market Cap
8.94B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.85B434.69M17.97%
Dec 31, 20232.42B323.19M15.42%
Dec 31, 20222.10B249.76M13.53%
Dec 31, 20211.85B-14.18M-0.76%
Dec 31, 20201.86B156.41M9.18%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
GSK plc 31.38B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Oxford Nanopore Technologies 183.19M
Revenue Rankings

BioMarin Pharmaceutical News

More News